ALT vs MCD · rev $20.0K vs P/E 23, rev $25.92B
Altimmune Inc (ALT) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
ALT currently screens at market cap $527.0M. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the ALT and MCD stock pages for the full models.
Not investment advice.